By Mill Chart
Last update: Jan 17, 2024
Unearth the potential of RESMED INC (NYSE:RMD) as a dividend stock recommended by our stock screening tool. NYSE:RMD maintains a robust financial footing and delivers a sustainable dividend. We'll delve into the details below.
ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NYSE:RMD earns a 7 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:RMD, the assigned 7 reflects its health status:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:RMD was assigned a score of 8 for profitability:
More Best Dividend stocks can be found in our Best Dividend screener.
Our latest full fundamental report of RMD contains the most current fundamental analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
RESMED INC
NYSE:RMD (4/22/2024, 6:00:00 PM)
After market: 180.35 0 (0%)180.35
+1.5 (+0.84%)
Which S&P500 stocks are moving before the opening bell on Monday?
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
These S&P500 stocks are moving in today's session
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.